1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Liver cancers

Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments [ID6388]

Awaiting development [GID-TA11468] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 30259-Zanidatamab-for-Biliary-Tract-Cancer-V2.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)